A067290 Share Price Performance
₩2,410.00
866.19 (56.11%)
Price ₩2,410.00
Share Pricen/a
JW Shinyak Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A067290 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
JW Shinyak Corporation Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- 244.87
- 50.11%
- 16.88%
- 2.2%
About A067290
- Founded
- 1981
- Employees
- n/a
- CEO
- WebsiteView website
JW Shinyak Corporation engages in the research, development, production, and sale of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatment, etc. using immune cells. JW Shinyak Corporation was founded in 1981 and is headquartered in Gwacheon-si, South Korea.
